Smart Inhaler for Asthma

(IDD Trial)

This trial tests a new smart inhaler for children with asthma who also have intellectual or developmental disabilities (IDD), such as autism. The smart inhaler guides users to take their medicine correctly by providing guidance and feedback. The trial aims to determine if using this inhaler at home can improve medication adherence and asthma management. It seeks participants aged 10-17 with moderate-to-severe asthma and IDD, whose parents have a smartphone and are willing to use an app linked to the inhaler. Participants will use either a smart inhaler that provides active feedback or one that only monitors use for eight weeks. As an unphased trial, this study offers a unique opportunity to contribute to innovative asthma care solutions for children with IDD.

Research has shown that smart inhalers are generally safe for people with asthma. These devices assist users in taking their medication correctly by providing feedback on inhaler use. Studies have examined the role of smart inhalers in helping people adhere to their treatment plans and found them effective.

Although specific information about side effects of smart inhalers is lacking, they resemble regular inhalers, which are widely used and considered safe. The primary difference is that smart inhalers include digital features, such as tracking usage and sending reminders, to enhance treatment. Therefore, any risks would likely mirror those of regular inhalers, which are usually well-tolerated.

Researchers are excited about the smart inhaler for asthma because it offers a fresh approach to managing the condition. Unlike traditional inhalers, which rely solely on the user’s ability to remember and properly use them, the smart inhaler integrates technology to actively track and remind patients about their medication usage. This means users can receive real-time feedback and maintain better control over their asthma. This tech-savvy approach not only aims to improve adherence but could also lead to more personalized asthma management by collecting valuable usage data.

Research has shown that smart inhalers can effectively manage asthma. One study found that people using a digital inhaler system were 85.3% more likely to control their asthma better than those who did not use it. Another study demonstrated that smart inhalers reduced asthma flare-ups and improved adherence to medication plans. Although some studies reported mixed results regarding asthma control and quality of life, the overall evidence suggests that smart inhalers support proper medication use and asthma management.